Prostaglandins in heart transplantation

Advances in Experimental Medicine and Biology

Volumn 433, Issue , 1997, Pages 19-22

  Iberer, F ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CREATININE; CYCLOSPORIN A; DOBUTAMINE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN E1; TROPONIN T; VASODILATOR AGENT;

ARTICLE; ASSISTED CIRCULATION; CLINICAL PROTOCOL; GRAFT FAILURE; GRAFT REJECTION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG VASCULAR RESISTANCE; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY;

EID: 0031391231     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1810-9_4     Document Type: Article

References (16)

1. 1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension J.Heart Lung Transplant; 11: 716-23 (1992)
2. 1 in heart transplant candidates. British Journal of Anaestesia 76; Suppl 1: Abstract A26 (1996)
3. Murali S, Uretzky BF, Reddy PS et al. Reversibility of pulmonary hypertension in congestive heart failure in patients evaluated for cardiac transplantation: Comparative effects of various pharmacologic agents. Am Heart J; 122(5):1375-81 (1991)
4. 1 - induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of oHTX. J Heart Lung Transplant; 12: 173-8 (1993)
5. 1, and sodium nitroprusside. J. Heart Lung Transplant; 14: 436-43 (1995)
6. 1 infusion for right ventricular failure after cardiac transplantation. J.Thorac Cardiovasc Surg ; 103: 33-9 (1992)
7. 1 reduces the frequency of rejection after heart transplantation. J Heart Lung Transplant; 11: 727-32 (1992)
8. Bathia S, Kirshenbaum J, Shemin R et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac TX. Circulation; 4: 819-26(1987)
9. Hausdorf G, Banner NR, Mitchell A, Khaghani A, Marin M, Yacoub M. Diastolic function after cardiac and heart-lung transplantation. Br Heart J; 62:123-32 (1989)
10. Halwachs G, Iberer F, Pieber T et al.:Troponin T as a marker for posttransplantation adaptional problems of the donor heart. J Heart Lung Transplant; 15:451-455 (1996)
11. Iberer F, Müller H, Wasler A et al. Prostaglandin E1 and heart transplantation. In Körner MM, Posival H, Körfer R (eds): Thoracic organ transplantation. Routine as a challenge. Elsevier Science B.V. (1994)
12. 1 therapy on Cyclosporine A and creatinine levels after orthotopic heart transplantation. Transplantation proceedings 26;6:3246-3248 (1994)
13. 1 effects in patients with severe dilated cardiomyopathy undergoing evaluation for HTX. J Heart Lung Transplant; 14 (3): 572-8 (1995)
14. Naeije R, Lipski A, Abramowicz M et al. Nature of pulmonary hjpertension in congestive heart failure. Effects of cardiac transplantation. Am J Respir Crit Care Med; 194: 881-7 (1994)
15. 1 infusion in catecholamine-dependent heart failure: Results of a prospective, randomized, controlled study. Crit Care Med; 22:1084-90 (1994)
16. 1 bridge to cardiac transplantation: technique, dosage, results. British Heart J; in press